Have you used GLP-1 medications or any other prescription weight-loss drugs in the past 45 days?
Examples: Semaglutide, Tirzepatide, Mounjaro, Wegovy, Ozempic, Phentermine, Contrave, etc.
All options include telehealth consultation, prescription, and delivery.
Your prescriber will review and confirm the appropriate dose.
All options include telehealth consultation, prescription, and delivery.
*Actual vial appearance, contents, and dosage may vary and is based on your prescription.
PT-141 has been studied for its action on melanocortin receptors in the brain, which are involved in sexual desire and arousal signaling rather than direct blood-flow mechanisms.
https://pubmed.ncbi.nlm.nih.gov/28778618/
Unlike PDE-5 inhibitors, PT-141 does not rely on nitric oxide or vascular dilation, making it mechanistically distinct in research literature.
https://pubmed.ncbi.nlm.nih.gov/21427119/
Clinical studies have evaluated PT-141 in male and female populations for effects related to sexual desire and arousal under specific conditions.
https://pubmed.ncbi.nlm.nih.gov/19887552/
PT-141’s mechanism of action is centered on hypothalamic and limbic pathways associated with motivation and desire.
https://pubmed.ncbi.nlm.nih.gov/17009063/
Research has examined PT-141 in populations where psychological or neurologic signaling plays a role in sexual response.
https://pubmed.ncbi.nlm.nih.gov/21427119/
PT-141 injections are prescribed by licensed healthcare providers based on an individual clinical evaluation and medical eligibility. Compounded formulations are not FDA-approved, and their safety and effectiveness have not been independently evaluated by the FDA.
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational purposes only and does not constitute medical advice. All care and prescriptions are provided solely at the discretion of a licensed healthcare provider following an individual evaluation.
Below are peer-reviewed studies and authoritative publications related to PT-141 (bremelanotide):
Replace with the Our Community intro copy describing your members and their experience.
Replace with the first member testimonial. Share what they have to say about their journey, results, and experience with Celara.
Replace with the first member testimonial. Share what they have to say about their journey, results, and experience with Celara.
Quick answers to common questions, designed to help you feel clear and confident as you explore Celara Med.
No. PT-141 is not a hormone and does not affect testosterone or estrogen levels. It works through central nervous system signaling pathways.
https://pubmed.ncbi.nlm.nih.gov/28778618/
No. PT-141 does not work through vascular dilation or nitric oxide pathways. Its mechanism is centrally mediated rather than blood-flow based.
https://pubmed.ncbi.nlm.nih.gov/21427119/
Adults experiencing concerns related to sexual desire or arousal signaling may be evaluated by a licensed healthcare provider. Eligibility is determined through individual clinical review.
PT-141 is administered via subcutaneous injection, as directed by a licensed healthcare provider. Instructions are provided during onboarding.
Some individuals may experience temporary side effects such as nausea, flushing, headache, increased blood pressure, or injection site irritation. Side effects vary and should be discussed with a provider.
In some cases, a provider may approve PT-141 in combination with other wellness or sexual-health–focused therapies, depending on individual needs and clinical appropriateness.
PT-141 injections through Celara Med are available in 48 states, excluding Alabama and Mississippi, subject to provider licensure and state regulations.
Yes. PT-141 is offered within a structured care plan designed to support appropriate use, monitoring, and clinical oversight.
Explore other provider-guided options that may better align with your goals.
Tadalafil is a phosphodiesterase type-5 (PDE-5) inhibitor that has been extensively studied for its role in vascular smooth muscle relaxation and blood-flow regulation.
PT-141, also known as bremelanotide, is a synthetic peptide studied for its effects on central nervous system signaling related to sexual desire and arousal. Unlike therapies that act primarily on vascular or nitric oxide pathways, PT-141 works through melanocortin receptors in the brain, influencing desire and arousal signaling at a neurologic level.